CDRE Cadre Holdings, Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1860543 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY18.3%
TTM net income YoY-9.4%
TTM EPS YoY-18.0%
Revenue 3-yr CAGR15.0%
Net income 3-yr CAGR4.9%
Margins
Gross margin42.0%
Operating margin10.7%
Net margin5.6%
FCF margin10.4%
EBITDA margin13.9%
Returns
ROE11.6%
ROA4.8%
ROIC (approx.)9.0%
Asset turnover0.85x
Leverage & solvency
Liabilities / assets60.2%
Debt / equity1.01x
Current ratio2.35x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.16x
Accruals ratio-5.6%
Payout ratio40.6%
Capex / revenue1.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $610.31M | $567.56M | $482.53M | $457.84M | $427.29M |
| Cost of revenue | $350.68M | $334.08M | $281.81M | $282.16M | $256.60M |
| Gross profit | $259.63M | $233.48M | $200.73M | $175.68M | $170.69M |
| R&D expense | $11.40M | $8.38M | $6.95M | $7.09M | $6.46M |
| SG&A expense | $183.13M | $158.32M | $140.52M | $153.13M | $114.96M |
| Operating income | $67.35M | $66.76M | $56.52M | $16.72M | $51.72M |
| Interest expense | — | $7.82M | $4.53M | $6.21M | $16.43M |
| Pretax income | $62.33M | $54.22M | $52.92M | $9.37M | $19.19M |
| Income tax | $18.19M | $18.09M | $14.28M | $3.55M | $6.53M |
| Net income | $44.14M | $36.13M | $38.64M | $5.82M | $12.66M |
| EBITDA | $85.98M | $83.18M | $72.26M | $32.37M | $65.44M |
| EPS (basic) | 1.08 | 0.90 | 1.03 | 0.16 | 0.44 |
| EPS (diluted) | 1.02 | 0.90 | 1.02 | 0.16 | 0.44 |
| Dividends declared per share | 0.10 | 0.09 | 0.08 | 0.08 | — |
| Weighted avg. shares (diluted) | 43.43M | 40.33M | 37.92M | 36.12M | 28.60M |
| Banking | |||||
| Deposits | $32.46M | $10.00M | $9.76M | $10.14M | $7.59M |
| Balance sheet | |||||
| Cash & equivalents | $122.90M | $124.93M | $87.69M | $45.29M | $33.86M |
| Receivables | $110.61M | $93.52M | $58.36M | $64.56M | $48.34M |
| Inventory | $100.26M | $82.35M | $80.98M | $70.27M | $63.98M |
| Current assets | $365.87M | $327.57M | $245.84M | $197.02M | $159.98M |
| PP&E, net | $78.82M | $45.24M | $44.65M | $45.28M | $33.05M |
| Goodwill | $181.41M | $148.16M | $81.67M | $81.58M | $66.26M |
| Intangibles | $114.98M | $107.54M | $43.47M | $50.70M | $42.41M |
| Total assets | $770.03M | $652.71M | $431.18M | $391.95M | $311.80M |
| Current liabilities | $104.50M | $94.12M | $95.21M | $78.92M | $74.62M |
| Short-term debt | $16.27M | $11.38M | $12.32M | $12.21M | $13.17M |
| Long-term debt | $290.99M | $211.83M | $127.81M | $137.48M | $146.52M |
| Total debt | $307.25M | $223.21M | $140.13M | $149.69M | $159.69M |
| Total liabilities | $452.23M | $341.20M | $234.02M | $226.06M | $223.16M |
| Shareholders' equity | $317.80M | $311.51M | $197.16M | $165.89M | $88.64M |
| Net debt | $184.35M | $98.27M | $52.44M | $104.40M | $125.83M |
| Shares outstanding | 42.16M | 40.61M | 37.59M | 37.33M | 34.38M |
| Cash flow statement | |||||
| Operating cash flow | $63.70M | $31.78M | $73.21M | $46.41M | $40.09M |
| Capital expenditure | $6.86M | $5.67M | $6.73M | $4.49M | $2.83M |
| Free cash flow | $56.85M | $26.11M | $66.48M | $41.91M | $37.26M |
| Investing cash flow | -$96.37M | -$147.43M | -$6.52M | -$59.63M | -$2.83M |
| Financing cash flow | $31.59M | $152.67M | -$24.72M | $24.46M | -$6.60M |
| Depreciation & amortization | $18.63M | $16.42M | $15.74M | $15.65M | $13.72M |
| Stock-based compensation | $12.24M | $8.37M | $9.37M | $31.86M | $355,000 |
| Dividends paid | $15.45M | $13.95M | $12.01M | $11.51M | $12.75M |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.